Communicable diseases
... STDs are not a problem with teens FACT: 2/3 of all STD cases occur to ...
... STDs are not a problem with teens FACT: 2/3 of all STD cases occur to ...
BBP QUIZ - Louisburg USD 416
... low, blood is the number one source of these viruses in the work place. Most people infected on the job were stuck by a contaminated needle or other sharp object, or had contaminated blood splash into broken skin, eyes or mouth. F - Although your risk of contracting one of these viruses at school ...
... low, blood is the number one source of these viruses in the work place. Most people infected on the job were stuck by a contaminated needle or other sharp object, or had contaminated blood splash into broken skin, eyes or mouth. F - Although your risk of contracting one of these viruses at school ...
PowerPoint Presentation - Energy Training Council
... cannot fight other deadly diseases. AIDS is a fatal disease, and while treatment for it is improving, there is no known cure. ...
... cannot fight other deadly diseases. AIDS is a fatal disease, and while treatment for it is improving, there is no known cure. ...
Infection Control
... • One or more drugs can no longer kill TB bacteria. • High risk persons for MDR TB: – Persons who did not take their TB meds. – Immunocompromised persons, i.e. cancer, HIV infection. – Persons previously treated for TB with an ineffective regimen of drugs. ...
... • One or more drugs can no longer kill TB bacteria. • High risk persons for MDR TB: – Persons who did not take their TB meds. – Immunocompromised persons, i.e. cancer, HIV infection. – Persons previously treated for TB with an ineffective regimen of drugs. ...
Wildlife diseases in South Africa: a review
... pandemic of 1898-1903, when the disease entered N o r t h Africa from Asia and swept south, killing millions of cattle and countless wild animals. M a n y of the current anomalies of wildlife distribution in Africa can be traced to this panzootic. Its unexpected sequels included the disappearance of ...
... pandemic of 1898-1903, when the disease entered N o r t h Africa from Asia and swept south, killing millions of cattle and countless wild animals. M a n y of the current anomalies of wildlife distribution in Africa can be traced to this panzootic. Its unexpected sequels included the disappearance of ...
KOZLENKO T
... As inactivator of the virus we used formalin (an aqueous solution of 38 % formaldehyde) in amounts of 0,1 %, 0,2 % and 0,5 %. We used the exposure from 24 to 120 hours at 37 °C. The completeness of inactivation determined holding 3 consecutive passages inactivated virus in cell culture CrFK. Result ...
... As inactivator of the virus we used formalin (an aqueous solution of 38 % formaldehyde) in amounts of 0,1 %, 0,2 % and 0,5 %. We used the exposure from 24 to 120 hours at 37 °C. The completeness of inactivation determined holding 3 consecutive passages inactivated virus in cell culture CrFK. Result ...
CALF PNEUMONIA....AN OVERVIEW There has been
... damage the lungs allowing the mycoplasmas and bacteria such as Pasteurella to wreak havoc. It is a relatively simple task to identify what bugs are present on your farm. Naso-pharangeal swabs taken early in the outbreak can give rapid answers and blood samples taken at the start of a problem then re ...
... damage the lungs allowing the mycoplasmas and bacteria such as Pasteurella to wreak havoc. It is a relatively simple task to identify what bugs are present on your farm. Naso-pharangeal swabs taken early in the outbreak can give rapid answers and blood samples taken at the start of a problem then re ...
HYGIENE AND COMMUNICABLE DISEASES
... tekhne ‘art of health’, from hugies ‘healthy’. → conditions or practices that help to maintain health and prevent disease, especially cleanliness. ...
... tekhne ‘art of health’, from hugies ‘healthy’. → conditions or practices that help to maintain health and prevent disease, especially cleanliness. ...
Replication Kinetic of Infectious Laryngotracheitis Virus in
... essential for the rapid and accurate differential diagnosis ofILTVs. Here the ability on an established chicken-origin cell for replication of ILTV strains was studied. In our experiments, both virulent and vaccine ILTV strains replicated well in CNS cell but only the vaccine strain produced marked ...
... essential for the rapid and accurate differential diagnosis ofILTVs. Here the ability on an established chicken-origin cell for replication of ILTV strains was studied. In our experiments, both virulent and vaccine ILTV strains replicated well in CNS cell but only the vaccine strain produced marked ...
Chickenpox - sarabrennan
... You are contagious 1-2 days before the first symptoms appear • Most contagious in the first 2-5 days after symptoms appear • No longer contagious after 10-14 days ...
... You are contagious 1-2 days before the first symptoms appear • Most contagious in the first 2-5 days after symptoms appear • No longer contagious after 10-14 days ...
Bio-Terrorism and the Respiratory Therapist
... • Dx: Seriologic Testing for antibodies. • Tx: Antibiotics--Doxycycline & quinolones for 4 years. Vaccine in Australia, but not US. ...
... • Dx: Seriologic Testing for antibodies. • Tx: Antibiotics--Doxycycline & quinolones for 4 years. Vaccine in Australia, but not US. ...
Bacteria And Viruses - American Training School
... 1. They are energy –less. They float around until they come in contact with an appropriate cell. 2. They are basic life forms composed of a protein coat, called a capsid, that surrounds genetic material. 3. Viruses do not have organelles or ribosomes. Certain viruses are futher enclosed by an extern ...
... 1. They are energy –less. They float around until they come in contact with an appropriate cell. 2. They are basic life forms composed of a protein coat, called a capsid, that surrounds genetic material. 3. Viruses do not have organelles or ribosomes. Certain viruses are futher enclosed by an extern ...
tackling emerging and re-emerging infectious diseases
... Priority 1: Prevent ZIKV Infection There is currently no licensed ZIKV vaccine available, however… § Vaccine for other flaviviruses have been developed and used for over 70 years § Active development programs for Dengue and West Nile vaccines have been ongoing for over 30 years, exploring a varie ...
... Priority 1: Prevent ZIKV Infection There is currently no licensed ZIKV vaccine available, however… § Vaccine for other flaviviruses have been developed and used for over 70 years § Active development programs for Dengue and West Nile vaccines have been ongoing for over 30 years, exploring a varie ...
Orchid Virus Diseases in Taiwan and their Control Strategies
... 1. Producing virus clean orchids is a win-win situation for propagators and finished plants providers. 2. All partners in the orchid production chain should implement serious sanitation and strict production procedures to prevent virus spread. 3. However, it is difficult for nurseries to guarantee a ...
... 1. Producing virus clean orchids is a win-win situation for propagators and finished plants providers. 2. All partners in the orchid production chain should implement serious sanitation and strict production procedures to prevent virus spread. 3. However, it is difficult for nurseries to guarantee a ...
Bloodborne Pathogens
... to permanent liver damage as well as cirrhosis, liver cancer, liver failure, chronic liver disease and death. Every year, thousands of people in the United States die from the virus. Although treatments for hepatitis C are becoming more effective, a cure cannot be ...
... to permanent liver damage as well as cirrhosis, liver cancer, liver failure, chronic liver disease and death. Every year, thousands of people in the United States die from the virus. Although treatments for hepatitis C are becoming more effective, a cure cannot be ...
Bio-Terrorism and the Respiratory Therapist
... • Dx: Seriologic Testing for antibodies. • Tx: Antibiotics--Doxycycline & quinolones for 4 years. Vaccine in Australia, but not US. ...
... • Dx: Seriologic Testing for antibodies. • Tx: Antibiotics--Doxycycline & quinolones for 4 years. Vaccine in Australia, but not US. ...
Subclinical infection
... –Viral antigenecity is single or steady –Viramia –Variation of virus surface Ags. ...
... –Viral antigenecity is single or steady –Viramia –Variation of virus surface Ags. ...
Threat of Mosquito-Borne Human Viral Diseases
... The initial clinical manifestations are very similar among mosquito-borne viral diseases; with a short incubation period, symptoms that may begin three to six days after infection, and fever, arthralgia, headache, shivers, anorexia,nausea and vomiting during acute phase. Majority of inflicting patie ...
... The initial clinical manifestations are very similar among mosquito-borne viral diseases; with a short incubation period, symptoms that may begin three to six days after infection, and fever, arthralgia, headache, shivers, anorexia,nausea and vomiting during acute phase. Majority of inflicting patie ...
Current Human Issues with H1N1
... So If I Catch It, How Long Do I Have To Stay At Home? • Rule for most people: ...
... So If I Catch It, How Long Do I Have To Stay At Home? • Rule for most people: ...
Who Is At Risk Of Exposure To H5N1 Avian Influenza
... So If I Catch It, How Long Do I Have To Stay At Home? • Rule for most people: ...
... So If I Catch It, How Long Do I Have To Stay At Home? • Rule for most people: ...
Virus Replication Cycle - Cal State LA
... • Host cell protein in virus envelope (cyclophilin A) initially binds HIV to low affinity receptor (heparin sulfate) of the cell • Followed by binding of viral ligand (gp120) to primary receptor (CD4) on T helper cells, macrophages, and ...
... • Host cell protein in virus envelope (cyclophilin A) initially binds HIV to low affinity receptor (heparin sulfate) of the cell • Followed by binding of viral ligand (gp120) to primary receptor (CD4) on T helper cells, macrophages, and ...
Current Human Issues with H1N1
... So If I Catch It, How Long Do I Have To Stay At Home? • Rule for most people: ...
... So If I Catch It, How Long Do I Have To Stay At Home? • Rule for most people: ...
Production of infectious swine vesicular disease virus from cloned
... used (Inoue et al., 1989). The plasmid pUCS825 containing Y-terminal cDNA (nucleotides 1 to 65) was newly prepared by the method of Geliebter (1987) with several modifications. These five clones overlap with each other. On the basis of these overlapping restriction sites, the construction steps were ...
... used (Inoue et al., 1989). The plasmid pUCS825 containing Y-terminal cDNA (nucleotides 1 to 65) was newly prepared by the method of Geliebter (1987) with several modifications. These five clones overlap with each other. On the basis of these overlapping restriction sites, the construction steps were ...
J Inf diseases 1999
... fever [5]. During the epidemic in Yambuku in 1976, 19 abortions (23%) among 82 pregnant women with EHF were reported [2]. There are several factors that may explain the high incidence of abortions: pyrexia, intravascular coagulopathy, and EBO infection in fetuses of EBO-infected women. In Yambuku, a ...
... fever [5]. During the epidemic in Yambuku in 1976, 19 abortions (23%) among 82 pregnant women with EHF were reported [2]. There are several factors that may explain the high incidence of abortions: pyrexia, intravascular coagulopathy, and EBO infection in fetuses of EBO-infected women. In Yambuku, a ...
Ebola virus disease
Ebola virus disease (EVD; also Ebola hemorrhagic fever, or EHF), or simply Ebola, is a disease of humans and other primates caused by ebolaviruses. Signs and symptoms typically start between two days and three weeks after contracting the virus with a fever, sore throat, muscular pain, and headaches. Then, vomiting, diarrhea and rash usually follow, along with decreased function of the liver and kidneys. At this time some people begin to bleed both internally and externally. The disease has a high risk of death, killing between 25 and 90 percent of those infected, with an average of about 50 percent. This is often due to low blood pressure from fluid loss, and typically follows six to sixteen days after symptoms appear.The virus spreads by direct contact with body fluids, such as blood, of an infected human or other animals. This may also occur through contact with an item recently contaminated with bodily fluids. Spread of the disease through the air between primates, including humans, has not been documented in either laboratory or natural conditions. Semen or breast milk of a person after recovery from EVD may still carry the virus for several weeks to months. Fruit bats are believed to be the normal carrier in nature, able to spread the virus without being affected by it. Other diseases such as malaria, cholera, typhoid fever, meningitis and other viral hemorrhagic fevers may resemble EVD. Blood samples are tested for viral RNA, viral antibodies or for the virus itself to confirm the diagnosis.Control of outbreaks requires coordinated medical services, alongside a certain level of community engagement. The medical services include rapid detection of cases of disease, contact tracing of those who have come into contact with infected individuals, quick access to laboratory services, proper healthcare for those who are infected, and proper disposal of the dead through cremation or burial. Samples of body fluids and tissues from people with the disease should be handled with special caution. Prevention includes limiting the spread of disease from infected animals to humans. This may be done by handling potentially infected bush meat only while wearing protective clothing and by thoroughly cooking it before eating it. It also includes wearing proper protective clothing and washing hands when around a person with the disease. No specific treatment or vaccine for the virus is available, although a number of potential treatments are being studied. Supportive efforts, however, improve outcomes. This includes either oral rehydration therapy (drinking slightly sweetened and salty water) or giving intravenous fluids as well as treating symptoms.The disease was first identified in 1976 in two simultaneous outbreaks, one in Nzara, and the other in Yambuku, a village near the Ebola River from which the disease takes its name. EVD outbreaks occur intermittently in tropical regions of sub-Saharan Africa. Between 1976 and 2013, the World Health Organization reports a total of 24 outbreaks involving 1,716 cases. The largest outbreak is the ongoing epidemic in West Africa, still affecting Guinea and Sierra Leone. {{#section:Ebola virus epidemic in West Africa|casesasof}}, this outbreak has {{#section:Ebola virus epidemic in West Africa|cases}} reported cases resulting in {{#section:Ebola virus epidemic in West Africa|deaths}} deaths.{{#section:Ebola virus epidemic in West Africa|caserefs}}